Related Experiment Video

Updated: Jun 12, 2026

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

Myc-induced microRNAs integrate Myc-mediated cell proliferation and cell fate

Jong Wook Kim1, Seiichi Mori, Joseph R Nevins

  • 1Duke Institute for Genome Sciences & Policy, Duke University Medical Center, Durham, North Carolina, USA.

Cancer Research
|June 3, 2010
PubMed

Insights

The Myc pathway regulates cell fate and proliferation. Myc-induced microRNAs (miRNAs) repress tumor suppressors like p21, p27, Rb, and PTEN, controlling cell proliferation and death.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Genetics

Background:

  • The Myc pathway is crucial for cell fate and proliferation, and its deregulation is common in cancer.
  • Precise control of Myc pathway activity is essential for normal cellular responses and preventing malignancy.
  • MicroRNAs (miRNAs) are increasingly recognized as key regulators of gene expression.

Purpose of the Study:

  • To investigate the role of miRNAs in executing Myc pathway functions.
  • To understand how miRNAs contribute to Myc-mediated gene regulation.

Main Methods:

  • Combined analysis of mRNA and miRNA expression profiles.
  • Investigated the regulatory relationship between Myc, miRNAs, and target genes.

Main Results:

  • Myc induces the expression of specific miRNAs.
  • These Myc-induced miRNAs repress the expression of tumor suppressor genes, including p21, p27, Rb, and PTEN.
  • This repression impacts the balance between cell proliferation and cell death.

Conclusions:

  • Myc-induced miRNAs play a significant role in Myc's control over cell proliferation and cell fate.
  • These miRNAs contribute to a transcriptional program that balances cell division and apoptosis.
  • Understanding this regulatory network offers insights into cancer development and potential therapeutic strategies.

More Related Videos

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene08:18

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene

Published on: December 31, 2014

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Related Concept Videos

Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...